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A B S T R A C T
Tuberculosis (TB) is a major cause of worldwide mortality. We report the case of a non-HIV-infected
woman with clinical suspicion of pleural tuberculosis and contradictory results between Xpert1 [4_TD$DIFF] MTB/
RIF and Abbott RealTime MTB assays from pleural ﬂuid specimen. Liquid and solid cultures for
tuberculosis were performed with negative results. The patient received treatment, and clinical
improvement was observed. Both techniques detectMycobacterium tuberculosis complex, but they have
different targets and limits of detection. Abbott RealTime MTB results correlated well with the clinical
ﬁndings of the patient.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Tuberculosis is a global public health problem. TheWorld Health
Organization recommends the use of nucleic acids ampliﬁcation
tests (NAAT) for diagnosis of tuberculosis in developing countries
and estimated that between 2000 and 2014 the effective diagnosis
and treatment saved 43 million lives.1,2
Xpert1 MTB/RIF (Cepheid, Sunnyvale, USA) ampliﬁes the rpoB
gen of Mycobacterium tuberculosis (MTB).3 Abbott RealTime MTB
(Abbott, Des Plaines, USA) detects both the insertion sequence
6110 and protein antigen B.4 We report the case of a woman with
clinical suspicion of pleural tuberculosis, culture negative and
contradictory results of two automated NAATs.
2. Case report
A 29-year-old woman from Valledupar (Colombia), HIV
negative, presented to the pneumology department with a clinical* Corresponding author[10_TD$DIFF]. Programa de Microbiologı´a- Universidad Popular del
Cesar, Valledupar - Colombia. Laboratorios Nancy Flo´rez Garcı´a S.A.S. Carrera 9 N8
7A-42. Tel.: +57 5 5716046 Valledupar- Colombia [2_TD$DIFF].
E-mail address: sorayaeugeniam@hotmail.com (S.E. Morales-Lo´pez).
http://dx.doi.org/10.1016/j.ijid.2016.11.011
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).picture of one month of evolving chest pain associated with cough,
fever and dyspnea. The patient was treated with prednisolone,
without clinical improvement.
In the physical examination shewas febrile, with tachypnea and
without abnormal respiratory noises in the lower lobe of the right
lung. There were no other ﬁndings of interest. A history of urinary
infection one month ago, treated with ciproﬂoxacin and cephalex-
in, was referred.
There was a suspicion of right-sided pneumonia and pleural
effusion. Empirical treatment with ampicillin sulbactam and
doxycycline was prescribed. Chest ultrasound conﬁrmed right
pleural effusion with an estimated volume of 610 mL ([11_TD$DIFF] igure 1A),
then thoracentesis was performed for treatment and diagnosis.
The citrine-yellow ﬂuid extracted showed lymphocytic pre-
dominance and elevated LDH level (928 IU/mL). An aliquot was
centrifuged at 3000 g for 20 minutes and the pellet was used for
Ziehl Neelsen, Gram,Wright and Chinese Ink stains. In all cases the
results were negative. Cultures in two Ogawa Kudoh solid media
were conducted, and PCR for identiﬁcation of MTB from pleural
ﬂuid was ordered.
The real-time PCR testing was performed according to the
protocols suggested by the manufacturers. After 120 minutes, the
results ‘‘MTB not detected’’ and ‘‘MTB detected’’ were generated for
Xpert1 [3_TD$DIFF] MTB/RIF and Abbott RealTime MTB, respectively.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
[(Figure_1)TD$FIG]
Figure 1. A. Obliteration of the costophrenic angle and Damoisseau sign with large pleural effusion. B. Reduction of pleural effusion without consolidation or cavitations.
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to the national TB reference laboratory for cultivation on
Middlebrook 7H9 broth using BACTEC Mycobacteria Growth
Indicator Tube-MGIT (Becton Dickinson, San Diego, USA). Addi-
tionally, in both laboratories the samples were inoculated in
Lowenstein-Jensen medium.
A second sample was processed 48 hours later, yielding the
same results. The clinician prescribed directly observed treatment
(DOT).
Two months later, all cultures remained negative and clinical
and radiological improvements were observed. Chest radiograph
revealed right-sided pleural effusion ([11_TD$DIFF] igure 1B). Complete clinical
remission and radiographic improvement was achieved in the
fourth month of treatment.
3. Discussion
Molecular assays have been reported to be suitable for
diagnosis of pleural tuberculosis. Hillemann et al., in Germany,
used Xpert1 MTB/RIF in 113 pleural liquid samples and found a
speciﬁcity of 98.1% compared to the culture.5 In India, Alvarez-Uria
et al., used Xpert1 MTB/RIF in 75 samples of pleural liquid and
obtained twice the positive results as with microscopy of
ﬂuorescence,6 and recently Pen˜ata et al.7 tested 48 pleural liquid
samples from patients in a high-level Colombian hospital using
Xpert1 MTB/RIF, reporting 100% sensitivity and speciﬁcity
compared with the culture.
On the contrary, WHO performed a meta-analysis of 17 studies
using Xpert1 MTB/RIF and cultures as the standard reference for
detection of MTB from pleural ﬂuid. Average sensitivity was low at
43.7% and speciﬁcity was around 98.1%.8
The detection of bacterial DNA in non-viable cells is common in
samples from patients undergoing pharmacological treatment.5,9
That can explain the cases in which NAAT was positive and culture
was negative. In our case, the patient declared she had not been
treated with antituberculosis drugs.
Other possible explanations for discordant results are technical
errors, the reduction of bacterial load caused by the decontamina-
tion procedure, and the presence of latent TB.9 In this case, the
molecular tests were repeated by different technicians, with thesame results; the sample came from a closed cavity, usually
considered sterile, so it was not subjected to decontamination and
the patient had signs and symptoms of TB, which eliminate the
possibility of latent tuberculosis.
There are no studies that compare Abbott RealTime MTB and
Xpert MTB/RIF using extrapulmonary samples. Wang et al. used
both tests in 255 sputum specimens, and they did not ﬁnd
statistical differences in sensitivity and speciﬁcity between them.
Discordant results between NAAT and culture were resolved using
16S–23S ITS rDNA sequencing.10
Sequencing is not available for routine clinical practice, which is
a limitation of this work. Another limitation was the use of pleural
ﬂuid instead of pleural biopsy, which is the preferred sample for
the conﬁrmation of pleural tuberculosis.8 However, NAAT are not
intended for testing extrapulmonary samples, except for Xpert
MTB/RIF in the case of cerebrospinal ﬂuid.
Xpert1 MTB/RIF and Abbott RealTime MTB provide greater
sensitivity than smear microscopy and more rapid results than
cultures. Both assays have been described in recent years, but to
date, only Xpert1 has been endorsed by WHO. The detection limit
of the Xpert1 MTB/RIF test is 131 CFU/mL and of the Abbott
RealTime MTB is 17 CFU/mL.3,9
In this case it was not possible to evaluate and discard the
presence of fastidious microorganisms. However, it is important to
mention that various authors have determined the analytical
speciﬁcity of both techniques: Tang9 tested 80 microorganisms
with Abbott RealTime MTB, including fastidious bacteria such as
Haemophilus inﬂuenzae, Legionella pneumophila, Chlamydia tracho-
matis, Chlamydia pneumoniae, Bordetella parapertussis; viruses;
nontuberculous Mycobacteria (NTM); common bacteria and
yeasts; the result was ‘‘MTB Not Detected’’ in all cases. Chen4
also tested 42 NTM using Abbott and all samples were determined
as MTB negative. On the other hand, Lawn3 used Xpert 1MTB/RIF
to test 20 isolates of NTM and all samples were negative for MTB,
showing high speciﬁcity, and Blakemore et al.11 tested 89 organ-
isms, including nutritionally demanding bacterias such as Borde-
tella pertussis, Bordetella parapertussis, Chlamydia pneumoniae,
Corynebacterium diptheriae, Haemophilus inﬂuenzae, Haemophilus
parainﬂuenzae, Haemophilus parahaemolyticus, Legionella pneumo-
phila, and Mycoplasma pneumoniae; common bacterias; fungi and
S.E. Morales-Lo´pez et al. / International Journal of Infectious Diseases 54 (2017) 36–3838viruses; and the Xpert assay did not mistakenly classify any of
these organisms as M. tuberculosis.
In the present case, the detection limit difference between the
NAAT could explain the discordant results, whereas the negative
result in cultures could be due to the paucibacillary nature of
pleural ﬂuid and to the effect of conservation and transportation
conditions on the viability of Mycobacterium.
Neither Abbott nor Xpert assays are recommended for pleural
ﬂuid samples according to their manufacturers. However, some
authors have used them to test this kind of sample and the
principal modiﬁcation in the testing of liquid samples was the
concentration by centrifugation before transferring them to the
cartridge.7,12 [12_TD$DIFF]
In our institution, the techniques are not validated for pleural
ﬂuid samples, however, the concentration step by centrifugation
was done as proposed by the authors mentioned.
Although other authors had already reported discrepancies
between NAAT and the culture, to date this is the ﬁrst report of
contradictory results in extrapulmonary samples using both
assays. Consequently, aside from the clinical ﬁndings, the
diagnosis of pleural tuberculosis must consider the limitations
of the methods for each kind of sample.
The ﬁndings reported here should be considered as a starting
point for projects with a larger number of non-respiratory samples
for comparing both techniques, and estimate the real advantage
between the two assays.
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